Replies to post #197360 on Amarin Corp Plc (AMRN)

[Cardiologymd]

I think they are doing a good job. I see ads in every major medical journal.
Their ads pop up when you try to read online medical news.
Reps are pretty good. They arrange a lot of educational dinners in my area.

[sts66]

Some here feel AMRN can’t effectively market Vascepa themselves in the US .

"Some" = one or two - cbb being one of them constantly pounding the table that only BP can properly sell V in the US. I believe the majority have come to realize based on comments from the docs here that sales reps have way less influence now than they used to, and many are simply barred from meeting with docs. 2000 reps may not be able to sell more V than 1000, but would cost a massive amount of (wasted) money. Education is likely best done via presentations at lunches and dinners, and as CME credits - then flood the consumer with DTC ads - much better use of marketing money IMO - can you imagine the impact of TV ads once AMRN is allowed to use the NNT #'s and show statistics like 30% reduction of multiple events? Another biggie we haven't seen analysis of yet is weight loss - that would be another big positive if R-IT patients had similar (inflammatory) weight loss as some here have reported (like moi).